Status:
COMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease
Lead Sponsor:
CENTOGENE GmbH Rostock
Conditions:
Wilson Disease
Eligibility:
All Genders
6-80 years
Brief Summary
Establishment of human cellular disease models for Wilson disease for an individualized therapy develop-ment having the capacity to address both hepatic and neurologic forms of the disease
Detailed Description
Wilson disease (WD) is caused by a defective gene for a copper-transporting protein that regulates cellular copper homeostasis in all major organs. Copper is an essential metal ion that is required fo...
Eligibility Criteria
Inclusion
- Informed consent will be obtained from the patient or the parents before any study related procedures.
- Patients of both genders older than 6 months and younger than 80 years
- The patient has a diagnosis of Wilson dis-ease
Exclusion
- No Informed consent from the patient or the parents before any study related procedures
- Patients of both genders younger than 6 months and older than 80 years
- No diagnosis of Wilson disease
Key Trial Info
Start Date :
June 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03867526
Start Date
June 19 2018
End Date
December 1 2019
Last Update
April 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital and Institute of Child Health, Ferozepur Road
Lahore, Pakistan, 54600